<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[CollaGenex Pharmaceuticals Inc. | Company News & Executive Profiles - CGPI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for CollaGenex Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="13" />
	<language>en-us</language>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Reports Financial Results for the Fourth Quarter and Full Year 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_12/ai_n24386714]]></link>
		<description><![CDATA[Total Revenues were $63.6 Million in 2007, including $52.5 Million of Oracea Net Sales  Signs Merger Agreement with Galderma Pharma S.A.  NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today reported financial results for the fourth quarter and year ended December 31, 2007.  Net revenues were $17.0 million...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229245.html]]></link>
		<description><![CDATA[ Earnings Call ExcerptCollaGenex Pharmaceuticals Inc. CGPI Q4 2007 Earnings Call March 12, 2008 11:00 am ET  Executives Evan Smith - IR Colin Stewart - President and CEO Presentation Operator Welcome to the CollaGenex Pharmaceutical fourth quarter 2007 financial results conference call. Operator Instructions. I would now like to...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 12 Mar 2008 08:54:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_April_23/ai_n19021986]]></link>
		<description><![CDATA[NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that the U.S. Patent and Trademark Office USPTO has posted on its Website a final rejection of CGPI's patent application No. 10/757,656 covering a method of treating acne using chemically modified tetracyclines, including incyclinide. The notice does not state the reason...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 23 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/rejection.html"><![CDATA[rejection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Announces USPTO Schedules for Issuance of Oracea Patent.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200704/ai_n19536985]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 April 2007-Afternoon Movers: CollaGenex  Pharmaceuticals Announces USPTO Schedules for Issuance of Oracea  PatentC1994-2007 M2 COMMUNICATIONS LTD    RDATE:12042007    Market Gainer is quickly emerging as the one stop shop for  international small-cap investors looking to stay a step ahead of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Provides Update on Oracea Patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_July_20/ai_n26932705]]></link>
		<description><![CDATA[NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that the U.S. Patent and Trademark Office USPTO has posted on its Website a nonfinal rejection of CGPI's patent application for Oracea.  On May 17, 2006, the Company announced that it had submitted additional information to the USPTO that may...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 20 Jul 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/rejection.html"><![CDATA[rejection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals to Present at the Fifth Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 15th]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_June_8/ai_n26890463]]></link>
		<description><![CDATA[NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin Stewart, president and chief executive officer, will present at the Fifth Annual Needham & Company, LLC Biotechnology and Medical Technology Conference. The presentation is scheduled for 4:00 p.m. EDT on Thursday, June 15, 2006, at the New York Palace...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 Jun 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Reports Notice of Allowance for European Patent Covering Oracea&#153;]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_March_21/ai_n26800720]]></link>
		<description><![CDATA[NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today reported that the European Patent Office has published on its web site that patent application 02731267.7 will be allowed. This patent has a priority date of April 5, 2002 and covers the use of sub anti-microbial doxycycline in the treatment of acne...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 21 Mar 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/allowance.html"><![CDATA[allowance]]></category>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[Roth Capital Partners 18th Annual Growth Stock Conference Presenter Profiles]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Feb_17/ai_n26766680]]></link>
		<description><![CDATA[DANA POINT, Calif. -- Roth Capital Partners 18th Annual Growth Stock Conference takes place Feb. 20-22 at the St. Regis Monarch Beach Resort & Spa in Dana Point, Calif. For in-depth information about the event visit http://www.rothcp.com/index06%20DP.html.  Below are profiles from Roth Capital Partners 18th Annual Growth Stock Conference...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 17 Feb 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amerigon+inc..html"><![CDATA[Amerigon Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/annual.html"><![CDATA[Annual]]></category>
		<category domain="http://resources.bnet.com/topic/antares+pharma+inc..html"><![CDATA[Antares Pharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/aspenbio+pharma+inc..html"><![CDATA[AspenBio Pharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/axt+inc..html"><![CDATA[AXT Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bentley+pharmaceuticals+inc..html"><![CDATA[Bentley Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bodisen+biotech+inc..html"><![CDATA[Bodisen Biotech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/california.html"><![CDATA[California]]></category>
		<category domain="http://resources.bnet.com/topic/clarient+inc..html"><![CDATA[Clarient Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/delta+financial+corp..html"><![CDATA[Delta Financial Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/diomed+holdings+inc..html"><![CDATA[Diomed Holdings Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/emrise+corp..html"><![CDATA[Emrise Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/geopharma+inc..html"><![CDATA[GeoPharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/medicalcv+inc..html"><![CDATA[MedicalCV Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merit+medical+systems+inc..html"><![CDATA[Merit Medical Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/middleby+corp..html"><![CDATA[Middleby Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mpa.html"><![CDATA[MPA]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/neogen+corp..html"><![CDATA[Neogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/netscout+systems+inc..html"><![CDATA[NetScout Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/network.html"><![CDATA[network]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/zi+corp..html"><![CDATA[Zi Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">APPY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AXTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BNT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BBCZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CLRT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DFCL Q</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DIO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ERI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GORX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCVI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MMSI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MIDD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NEOG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NTCT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ZICA</category>
		<category domain="tickers">ARGN,AIS,APPY,AXTI,BNT,BBCZ,CLRT,CGPI,DFCL Q,DIO,ERI,GORX,MCVI,MMSI,MIDD,NDAQ,NEOG,NTCT,PPHM,ZICA</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals Files Patent Infringement Claim against IVAX Pharmaceuticals Inc. and CorePharma LLC]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Oct_1/ai_n6216558]]></link>
		<description><![CDATA[NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI) today announced that it has filed a complaint for patent infringement against IVAX Pharmaceuticals Inc. and CorePharma LLC ("Defendants") in the United States District Court for the Eastern District of New York. CollaGenex alleges that the Defendants' submissions of Abbreviated New Drug Applications...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Oct 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/corepharma+llc.html"><![CDATA[Corepharma LLC]]></category>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
	<item>
		<title><![CDATA[CollaGenex Pharmaceuticals to Present at the UBS Warburg Global Specialty Pharmaceuticals Conference on June 6, 2002]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_May_30/ai_86467153]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  UBS Warburg Global Specialty Pharmaceuticals Conference  NEWTOWN, Pa.--BUSINESS WIRE--May 30, 2002  CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI) announced today that the Company's chairman, president and chief executive officer, Brian M. Gallagher, PhD, will present at the UBS Warburg Global Specialty Pharmaceuticals Conference.  The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 May 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collagenex+pharmaceuticals+inc..html"><![CDATA[CollaGenex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/ubs+warburg.html"><![CDATA[UBS Warburg]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGPI</category>
		<category domain="tickers">CGPI</category>
	</item>
</channel>
</rss>
